A mathematical model of in vitro cancer cell growth and treatment with the antimitotic agent curacin \(A\)
From MaRDI portal
Publication:5936129
DOI10.1016/S0025-5564(00)00065-1zbMath0978.92012OpenAlexW2091655350WikidataQ52066778 ScholiaQ52066778MaRDI QIDQ5936129
Billy W. Day, John Carl Panetta, Pao-Hsiu Chen, Frank P. Kozusko, Stephen G. Grant
Publication date: 16 January 2002
Published in: Mathematical Biosciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/s0025-5564(00)00065-1
antimitotic drugsapoptosiscell cycle phase-specific chemotherapycuracin Apharmacodynamic modelssystem of ordinary differential equations
Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45) Medical applications (general) (92C50)
Related Items
A microenvironment based model of antimitotic therapy of Gompertzian tumor growth, Cell resensitization after delivery of a cycle-specific anticancer drug and effect of dose splitting: learning from tumour cords, Optimization of additive chemotherapy combinations for an in vitro cell cycle model with constant drug exposures, Optimisation of Cancer Drug Treatments Using Cell Population Dynamics
Cites Work
- Reduction of cytotoxicity to normal tissues by new regimens of cell-cycle phase-specific drugs
- A theoretical analysis of interval drug dosing for cell-cycle-phase- specific drugs
- A mathematical model of breast and ovarian cancer treated with Paclitaxel
- A mathematical model of cycle-specific chemotherapy
- Unnamed Item